A Study to Evaluate Safety and Efficacy of PF-06826647 For Moderate To Severe Plaque Psoriasis

PHASE2CompletedINTERVENTIONAL
Enrollment

179

Participants

Timeline

Start Date

June 27, 2019

Primary Completion Date

May 21, 2020

Study Completion Date

November 26, 2020

Conditions
Psoriasis
Interventions
DRUG

PF-06826647 or Placebo

Delivered orally (tablet) once daily (QD) for 16 weeks during the Investigational Treatment Period

DRUG

PF-06826647

Delivered orally (tablet) once daily (QD) for 24 weeks during the Extension Period

Trial Locations (45)

30022

Hamilton Research, LLC, Alpharetta

32073

Advanced Diagnostic Group, Orange Park

Park Avenue Dermatology, Orange Park

32174

Leavitt Medical Associates of Florida d/b/a Ameriderm Research, Ormond Beach

33613

ForCare Clinical Research, Tampa

34470

Renstar Medical Research, Ocala

34471

MidState Skin Institute, Ocala

Renstar Medical Research, Ocala

42301

Qualmedica Research, LLC, Owensboro

42303

Owensboro Dermatology Associates, Owensboro

66215

Epiphany Dermatology of Kansas, LLC, Overland Park

70809

DelRicht Research, Baton Rouge

70816

DelRicht Research, Baton Rouge

74136

Vital Prospects Clinical Research Institute, PC, Tulsa

76011

Arlington Research Center, Inc., Arlington

85032

Alliance Dermatology and Mohs Center, Phoenix

85260

Center for Dermatology and Plastic Surgery/CCT, Scottsdale

Center for Dermatology and Plastic Surgery, Scottsdale

92024

California Dermatology & Clinical Research Institute, Encinitas

92103

Imaging Healthcare Specialists, San Diego

Medderm Associates Dermatology, San Diego

92123

University Clinical Trials, San Diego

92801

Anaheim Clinical Trials, LLC, Anaheim

93301

Kern Research. Inc., Bakersfield

R3M 3Z4

Wiseman Dermatology Research Inc., Winnipeg

K9A 0Z4

SKiN Health, Cobourg

L8N 1Y2

Dermatrials Research, Hamilton

L3P 1X3

Lynderm Research Inc., Markham

M3H 5Y8

Toronto Research Centre, Toronto

N2J 1C4

K. Papp Clinical Research, Waterloo

J1L 0H8

Centre Radiologique de l'Estrie, Sherbrooke

Diex Recherche Sherbrooke Inc., Sherbrooke

467-8602

Nagoya City University Hospital, Nagoya

173-8606

Teikyo University Hospital, Itabashi-ku

141-8625

NTT Medical Center Tokyo, Shinagawa-ku

161-8521

Seibo International Catholic Hospital, Shinjuku-ku

814-0180

Fukuoka University Hospital, Fukuoka

160-0023

Tokyo Medical University Hospital, Tokyo

30-510

Malopolskie Centrum Medyczn, Krakow

Pratia MCM Krakow, Krakow

02-106

MTZ Clinical Research Sp. z o.o., Warsaw

15-351

Zdrowie Osteo-Medic s.c. L. i A. Racewicz, A. i J. Supronik, Bialystok

15-375

SpecDerm Poznanska Sp. J., Bialystok

25-316

Prywatny Gabinet Dermatologiczny Elzbieta Klujszo, Kielce

21-040

Tomasz Blicharski Lubelskie Centrum Diagnostyczne, Swidnik, Lubelskie

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY